跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Remifentanil-AFT, remifentanil (as hydrochloride) 2 mg, powder for injection, glass vial - TGA Drug Approval Details
Approvals
/
TGA
/
Remifentanil-AFT, remifentanil (as hydrochloride) 2 mg, powder for injection, glass vial
Approved
STANDARD
Remifentanil-AFT, remifentanil (as hydrochloride) 2 mg, powder for injection, glass vial
AFT Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
9957c0f33cab592c
Company
AFT Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
9957c0f33cab592c
Product Name
Remifentanil-AFT, remifentanil (as hydrochloride) 2 mg, powder for injection, glass vial
Artg Id
194069
Artg Name
Remifentanil-AFT remifentanil (as hydrochloride) 2 mg powder for injection glass vial
Sponsor
AFT Pharmaceuticals Pty Ltd
Company Detail Path
/organization/aft-pharmaceuticals-au-pty-ltd
Artg Date
2013-03-20
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/b5ffaf4234addccb6d9f7839224e2778.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/9a7dca3c32eac4764cc1fd81354ac18a.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
9957c0f33cab592c
Type
Standard
Back to TGA Approvals